dc.creatorArana, Eloisa
dc.creatorFernandez, Pablo Mariano
dc.date.accessioned2020-07-31T20:28:38Z
dc.date.accessioned2022-10-15T06:40:56Z
dc.date.available2020-07-31T20:28:38Z
dc.date.available2022-10-15T06:40:56Z
dc.date.created2020-07-31T20:28:38Z
dc.date.issued2019-12
dc.identifierArana, Eloisa; Fernandez, Pablo Mariano; Going Forward with Lymphocytes Immunotherapies for Treatment of Unexplained Recurrent Spontaneous Abortion; BiomedGrid ; American Journal of American Journal of Biomedical Science & Research; 6; 5; 12-2019; 368-369
dc.identifier2642-1747
dc.identifierhttp://hdl.handle.net/11336/110693
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4356400
dc.description.abstractRecurrent spontaneous abortion (RSA), defined as the occurrence of two or more consecutive miscarriages at less than 22-weeks of gestation [1], is one of the major pregnancy disorders and affects up to 5% of couples of reproductive ages. Although genetic factors, hormonal diseases, anatomical anomalies and antiphospholipid syndrome have been linked with RSA [2,3], 50% of cases still remain unexplained and generate growing interest to unveil potential involved mechanism, particularly for those that imply immunological pathways
dc.languageeng
dc.publisherBiomedGrid
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.34297/AJBSR.2019.06.001063
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://biomedgrid.com/fulltext/volume6/going-forward-with-lymphocytes-immunotherapiesfor-treatment-of-unexplained-recurrent.001063.php
dc.rightshttps://creativecommons.org/licenses/by/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectABORTION
dc.subjectIMMUNITY
dc.subjectIMMUNOTHERAPY
dc.subjectTREATMENT
dc.titleGoing Forward with Lymphocytes Immunotherapies for Treatment of Unexplained Recurrent Spontaneous Abortion
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución